Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News

Welcome to the Cambridge Angels

Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News
PhoreMost signs AI-based pharma drug discovery agreement
14 September 2020
Cambridge Angels
PhoreMost signs AI-based pharma drug discovery agreement
Cambridge Angels
14 September 2020

PhoreMost signs AI-based pharma drug discovery agreement

Cambridge Angels
14 September 2020

Source:https://www.businessweekly.co.uk/killer-50/50-insider/phoremost-signs-ai-based-pharma-drug-discovery-agreement

Newer PostRoyal Academy awards celebrate engineering pioneers
Older PostNHSx unveils first winners of £50m AI in Health and Care Award
LI-In-Bug_small.png
Back to Top
Privacy
info@cambridgeangels.net